Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (HKG:3378)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
17.10
0.00 (0.00%)
At close: Jan 23, 2026
-46.56%
Market Cap2.33B
Revenue (ttm)2.34M
Net Income (ttm)-123.26M
Shares Out136.22M
EPS (ttm)-11.28
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume81,000
Average Volume354,695
Open16.90
Previous Close17.10
Day's Range16.88 - 17.15
52-Week Range13.48 - 32.00
Beta0.84
RSI16.92
Earnings Daten/a

About HKG:3378

Hanx Biopharmaceuticals (Wuhan) Co., Ltd. develops and manufactures immunotherapies for cancer and autoimmune diseases. The company's products include antibody drugs, including monoclonal, bispecific, and antibody drug conjugates for immuno-oncology pathways. The company was incorporated in 2014 and is headquartered in Wuhan, China. [Read more]

Founded 2014
Employees 55
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 3378
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements